Role of benefit-risk assessment and pharmaco-economics in decision-making of medicines
OBJECTIVESThis course gives you an introduction into the principles and methods of comparative Benefit-Risk assessment and their role of benefit-risk assessment in decision-making of medicines. The course provides insight in the changing health care environment and gives an overview of the different stakeholders that are involved in pharmacotherapeutic decision-making. Specific attention is given to the drivers and background of the different stakeholders and the rationale of benefit/risk and pharmacoeconomic evaluations in decision-making.
LEARNING OUTCOMESAt the end of the course, you will :
|
|
AUTHORS
![]() |
Prof. Olaf Klungel Universiteit Utrecht |
![]() |
Prof. Hubert Leufkens Universiteit Utrecht |
![]() |
Nasop Experts Group ISoP's North American chapter |